π¬ New ways to fight lung infections beyond antibiotics
Researchers are exploring host-directed therapies and phages for stubborn lung infections, moving past just killing microbes. Experts discussed these novel approaches at the European Respiratory Society (ERS) 2026 Congress in Barcelona, Spain. Various agents like MMP inhibitors and anti-inflammatory drugs are being studied for different infection stages and types. Current clinical use of these advanced therapies remains low, despite strong biological backing. Future research needs standardized outcomes to properly evaluate these promising treatments. π¬